Prostate cancer is a leading cause of
cancer-associated deaths in men over 60 years of age. Most patients are killed by
tumor metastasis. Recent evidence has implicated a role of the tumor microenvironment and
urokinase plasminogen activator (uPA) in
cancer cell migration, invasion, and
metastasis. Here, we examine the role of the Na+/H+ exchanger
isoform 1 (NHE1) and uPA in DU 145
prostate cancer cell migration and colony formation. Knockout of NHE1 reduced cell migration. The effects of a series of novel NHE1/uPA
hexamethylene-amiloride-based inhibitors with varying efficacy towards NHE1 and uPA were examined on
prostate cancer cells. Inhibition of NHE1-alone, or with inhibitors combining NHE1 or uPA inhibition-generally did not prevent
prostate cancer cell migration. However, uPA inhibition-but not NHE1 inhibition-prevented anchorage-dependent colony formation. Application of inhibitors at concentrations that only saturate uPA inhibition decreased
tumor invasion in vivo. The results suggest that while knockout of NHE1 affects cell migration, these effects are not due to NHE1-dependent
proton translocation. Additionally, while neither NHE1 nor uPA activity was critical in cell migration, only uPA activity appeared to be critical in anchorage-dependent colony formation of DU 145
prostate cancer cells and invasion in vivo.